title: Drugs treatment of pain in multiple sclerosis.
abstract: Pain is a frequent and disabling symptom among multiple sclerosis (MS) and it is estimated to occur in 55% to 65% of patients. The mechanism of pain in MS has not yet been defined, because it can result from somatic, visceral, emotional, or neurologic impairment. The importance of this classification is related to different medical approaches to treat the pain in MS patients. In the management of symptomatic pain, new therapeutic strategies are now available to represent a great opportunity improving the quality of life. The availability of newer drugs for symptomatic treatment of pain in MS indicates a need to pay attention to this problem.
authors.affiliation: Department of Neuroscience, Neurology Division, Annuziata Hospital, Cosenza, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Siniscalchi
authors.forename: Luca
authors.initials: L
authors.lastname: Gallelli
authors.forename: Giovambattista
authors.initials: G
authors.lastname: De Sarro
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications* / Q000503:physiopathology; D010146:Pain / Q000145:classification / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000928:Antidepressive Agents